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Abstract
Background—In the intensive care unit (ICU), delirium is routinely measured with the widely-
used, validated Confusion Assessment Method for the ICU (CAM-ICU), but CAM-ICU has not 
been studied in patients with cirrhosis. We studied a group of patients with cirrhosis to determine 
the relationship between delirium measured by CAM-ICU and clinical outcomes.
Methods—Consecutive patients with cirrhosis admitted to the ICU from 2009 to 2012 were 
included in a retrospective cohort study. Patients were screened twice daily for coma and delirium 
during their ICU stay using the Richmond Agitation Sedation Scale (RASS) and CAM-ICU. The 
association between delirium/coma and mortality was determined using multiple logistic 
regression. RASS and CAM-ICU were also compared to a retrospective assessment of hepatic 
encephalopathy (HE).
Results—Of 91 patients with cirrhosis, 26 (28.6%) developed delirium/coma. RASS/CAM-ICU 
had fair agreement with the HE assessment (κ 0.38). Patients with delirium/coma had numerically 
greater mortality in-hospital (23.1% vs. 7.7%, p = 0.07) and at 90 days (30.8% vs. 18.5%, p = 
0.26), and they also had longer hospital length of stay (median 19.5 vs. 6 days, p < 0.001). 
Delirium/coma was associated with increased inpatient mortality, independent of disease severity 
(unadjusted OR 3.6; 95% CI, 0.99–13.1; MELD-adjusted OR 5.4; 95% CI, 1.3–23.8; acute 
physiology score-adjusted OR 2.2; 95% CI, 0.53–8.9). Delirium/coma was also associated with 
longer length of stay after adjusting for disease severity.
Conclusion—In critically ill patients with cirrhosis, delirium/coma as measured by the RASS 
and CAM-ICU is associated with increased mortality and hospital length of stay. For these 
patients, these measures provide valuable information and may be useful tools for clinical care. 
RASS and CAM-ICU need to be compared to HE-specific measures in future studies.
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INTRODUCTION
Delirium is a neurologic disorder characterized by a fluctuating disturbance of attention and 
awareness with impaired cognition (Diagnostic and statistical manual of mental disorders 
2013). Delirium is common in hospitalized patients, and its presence, severity, and duration 
are associated with increased length of stay, costs, and mortality (Ely et al. 2004; Klein 
Klouwenberg et al. 2014; McAvay et al. 2006; Milbrandt et al. 2004; Young et al. 2010). 
Delirium is easily diagnosed using the Confusion Assessment Method (CAM), a simple 4-
item instrument with excellent test characteristics that a variety of healthcare providers can 
perform quickly and reproducibly (Inouye et al. 1990; Wong et al. 2010). CAM is 
recommended in more than 30 clinical practice guidelines, has been translated into over 20 
languages, and has been adapted for use in emergency rooms, nursing homes, and intensive 
care units (CAM-ICU) (Ely et al. 2001; Wei et al. 2008). CAM-ICU has been validated in 
multiple studies, and is recommended for routine clinical use by the Society of Critical Care 
Medicine (Barr et al. 2013; Gusmao-Flores et al. 2012; Jacobi et al. 2002).
Delirium can be caused by medical conditions such as liver failure, which causes hepatic 
encephalopathy (HE), and overt HE is defined as a subtype of delirium (Ferenci et al. 2002; 
Rosenberg et al. 2013). Overt HE is a significant burden to the health care system, with 
substantial associated mortality and costs, and it is unique to patients with liver disease 
(Stepanova et al. 2012). In patients with suspected HE, some authors have advocated 
screening for delirium with CAM (Cordoba 2011). CAM and CAM-ICU may have 
particular value in patients with cirrhosis because of their existing widespread use in clinical 
practice and because HE commonly causes delirium. However, CAM-ICU's performance in 
patients with cirrhosis is not known. Because of the unique contribution of HE to delirium in 
cirrhosis, standard delirium measurement in this population may differ from other 
populations. We aimed to determine the association between delirium measured by CAM-
ICU and clinical outcomes in critically ill patients with cirrhosis. We also examined CAM-
ICU in relation to overt HE because of the significant potential impact of HE on delirium 
measurement.
METHODS
Study Sample
Consecutive adult patients admitted to the ICUs of Wishard Memorial Hospital (WMH) 
between May 2009 and October 2012 were included in this retrospective cohort study. The 
cohort was comprised of patients who were being screened for eligibility for a randomized 
trial of delirium management (NCT00842608), which requires the presence of delirium as 
assessed by CAM-ICU. Patient selection and inclusion and exclusion criteria have been 
described previously (Campbell et al. 2011). In particular, patients were excluded if they had 
severe mental illness or alcohol-related delirium. The study took place at WMH, an urban, 
tertiary-care, county hospital affiliated with the Indiana University School of Medicine. At 
this hospital, medical school faculty and housestaff provide medical care.
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Screened patients' billing records were used to identify those with cirrhosis diagnostic codes 
(ICD-9-CM 456.0, 456.1, 456.2, 456.21, 567.23, 571.2, 571.5, 572.2, 572.3, 572.4, 789.59). 
This set of codes has been shown to be highly sensitive to the presence of cirrhosis (Nehra et 
al. 2013). For patients with these codes, we reviewed the electronic medical records to 
determine a definitive diagnosis of cirrhosis. This diagnosis was either proven histologically, 
or based on clinical, laboratory, endoscopic, and imaging characteristics. For patients 
screened during multiple hospital admissions, we only included the first admission. The 
study was approved by the Indiana University School of Medicine Institutional Review 
Board.
Delirium, Coma, and Hepatic Encephalopathy
Patients were screened twice daily in the ICU by trained research personnel using CAM-
ICU (Online Resource). CAM-ICU can be used to diagnose delirium on the basis of (1) an 
acute change or fluctuating course of mental status, (2) inattention, and either (3) an altered 
level of consciousness or (4) disorganized thinking. CAM-ICU can detect delirium with a 
sensitivity of 80% and specificity of 96% (area under the receiver operating characteristic 
curve 0.97); it has high interrater reliability; and it can be performed in patients who are 
intubated (Ely et al. 2001; Gusmao-Flores et al. 2012). Patients cannot be diagnosed with 
delirium if they are comatose; comatose patients are those who are unable to respond to 
verbal stimuli (Khan et al. 2012). Coma was therefore excluded immediately prior to CAM-
ICU using the Richmond Agitation Sedation Scale (RASS) (Online Resource). RASS has 
been shown to be a valid, appropriate instrument for this purpose and is commonly 
employed both in research settings and in practice (Ely et al. 2004; Ely et al. 2003; Khan et 
al. 2012). When the RASS score was ≤ −4, patients were considered comatose and not 
eligible for CAM-ICU assessment. Those with a positive CAM-ICU at any point during 
their ICU stay were considered to have delirium; those with a RASS ≤ −4 were considered 
to have coma.
Overt HE (West-Haven grade ≥ 2) was ascertained by independent review of the electronic 
medical record by two hepatologists. HE assessors were blinded to the results of RASS/
CAM-ICU. HE assessment was performed (1) on the same date as the first positive CAM-
ICU or RASS, or (2) for those without delirium or coma, on the date of first RASS/CAM-
ICU assessment. Discordant HE assessments were resolved by consensus.
Outcomes
The primary outcome was in-hospital mortality. The secondary outcomes were 90-day 
mortality and hospital length of stay. To determine mortality accurately, follow-up data were 
obtained using the Regenstrief Medical Record System, a comprehensive database capturing 
all inpatient and outpatient data including death certificate information for patients who die 
both inside and outside of Indiana.
Variables
In addition to delirium, coma, and outcomes, we assessed additional potential confounding 
variables. These included age, sex, race/ethnicity, etiology of cirrhosis, principal discharge 
diagnosis, the presence of hepatocellular carcinoma, and measures of disease severity. 
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Measures of disease severity were both cirrhosis-specific (Child-Pugh and Model for End-
Stage Liver Disease [MELD]) and general (acute physiology score [APS] derived from 
APACHE II (Knaus et al. 1985)).
Statistical Analysis
Continuous variables were reported as means (standard deviation) when normally 
distributed, or medians (interquartile range) otherwise, and categorical variables were 
reported as counts and proportions. Bivariate comparisons were made with the Wilcoxon 
rank-sum test for continuous variables, and Fisher's exact test for categorical variables. 
Concordance between RASS/CAM-ICU assessments and HE assessments were quantified 
using the κ statistic. The relationships between the composite exposure of delirium and/or 
coma (delirium/coma) and the outcomes were assessed using logistic regression for 
mortality and Poisson regression for length of stay. The composite of delirium/coma was 
chosen because coma is considered grade 4 overt HE according to the gold standard West-
Haven criteria. Overt HE is a subtype of delirium, and delirium cannot be diagnosed in the 
presence of coma, so the composite appeared most appropriate. We reported unadjusted 
models, as well as models adjusted for relevant confounders. Multivariate models were 
restricted to one or two covariates due to sample size limitations. All analyses were 
performed using SAS version 9.3.
RESULTS
Patient Characteristics
Of 3,147 patients screened for delirium/coma during 3,748 admissions, 91 had cirrhosis and 
were included in this analysis (Figure 1). The mean age was 55.8 years (SD 8.8), and 63.7% 
were male. 87.9% of patients had alcoholic liver disease or viral hepatitis. 76.7% of patients 
had Child-Pugh B or C cirrhosis, and the mean MELD was 14.1 (SD 7.8). 18 patients were 
receiving mechanical ventilation on the day of HE assessment. The most common reasons 
for admission were altered mental status, gastrointestinal bleeding, and infection. These 
diagnoses were specified from the principal hospital discharge diagnosis. Delirium/coma 
(positive CAM-ICU and/or RASS ≤ −4) was present in 26 (28.6%), and 18 (19.8%) had 
delirium without coma (positive CAM-ICU and RASS > −4). Patients with delirium/coma 
appeared slightly older than those without delirium/coma, were more likely to be female, 
and were less likely to have alcoholic liver disease (Table 1). APS was greater in the group 
with delirium/coma, but Child-Pugh scores and MELD were similar. None of the 5 patients 
with hepatocellular carcinoma had delirium/coma.
Delirium/Coma and HE
Interrater reliability for assessment of HE was good (κ 0.57). Disagreements were most 
common in intubated patients receiving sedation. After excluding those with coma, interrater 
reliability was slightly improved (κ 0.65). Overt HE was present in 22 (24.2%). 
Concordance between RASS/CAM-ICU and HE assessment was fair (κ 0.38) and was also 
improved when comatose patients were excluded (κ 0.45). Of the 22 patients with HE, 13 
screened positive for delirium/coma by RASS/CAM-ICU (sensitivity of RASS/CAM-ICU 
for HE = 59%; positive predictive value = 50%), whereas out of 69 patients without HE, 56 
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screened negative for delirium/coma by RASS/CAM-ICU (specificity of RASS/CAM-ICU 
= 81%; negative predictive value = 86%). RASS/CAM-ICU assessment was strongly 
dependent on whether patients were intubated (delirium/coma present in 78% of intubated 
patients vs. 16% of non-intubated patients, p < 0.001). In contrast, HE did not appear related 
to intubation status (HE in 28% of intubated vs. 23% of non-intubated, p = 0.76). In 
intubated patients, the sensitivity of RASS/CAM-ICU for HE was 100%, and specificity was 
31%; in non-intubated patients, the sensitivity of RASS/CAM-ICU was 47%, and specificity 
was 93%. Ammonia levels were similar in those with and without delirium/coma (Table 1) 
and in those with and without HE (47 [38–67] vs. 42 [35–75] μmol/L, p = 0.87).
Outcomes
11 patients died in the hospital (6 with delirium/coma), and an additional 9 died within 90 
days (2 with delirium/coma). Inpatient mortality was numerically greater for those with 
delirium/coma compared to those without (23.1% vs. 7.7%, p = 0.07), as was 90-day 
mortality (30.8% vs. 18.5%, p = 0.26). Excluding those with coma, mortality was also 
numerically greater for those with delirium both in-hospital (22.2% vs. 7.7%, p = 0.10) and 
at 90 days (33.3% vs. 18.5%, p = 0.20). Bivariate comparisons of demographic and clinical 
factors with mortality are presented in Table 2. Increasing APS, increasing MELD score, 
and increasing Child-Pugh score were associated with increased inpatient and 90-day 
mortality. In addition, HE was significantly associated with increased mortality at 90 days. 
Median length of hospital stay was longer in those with delirium/coma (19.5 vs. 6 days, p < 
0.001).
In multivariate analysis, delirium/coma remained associated with increased odds of inpatient 
and 90-day mortality. Table 3 shows the relationships between delirium/coma and outcomes 
adjusting for relevant confounders. Several of these models result in a weakening of these 
associations, with loss of statistical significance (particularly for 90-day mortality). 
However, the effect estimates of the models had consistent direction toward increased 
mortality with delirium/coma. The increase in length of stay for coma/delirium patients 
remained strong and consistent after adjusting for all variables. This increase was also 
apparent when restricting the analysis to the time after delirium assessment or diagnosis and 
in those who survived to discharge (data not shown).
DISCUSSION
Delirium is a form of acute brain dysfunction caused by an underlying medical condition. It 
occurs in hospitalized patients frequently, and is a particular concern in those with high 
illness acuity and multiple comorbidities (Fick et al. 2002; McNicoll et al. 2003; Siddiqi et 
al. 2006). Patients with cirrhosis are at high risk of developing delirium, due to a high 
prevalence of infections, frequent electrolyte disturbances and kidney injury, and HE 
(Belcher et al. 2013; Jepsen et al. 2010; Merli et al. 2010). In this study of critically ill 
patients with cirrhosis, we found that nearly 30% developed delirium or coma during their 
ICU stay. Those with delirium/coma had greater short-term mortality and spent more days in 
the hospital.
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Delirium assessment with CAM-ICU and RASS is a promising tool for the care of patients 
with cirrhosis. In this population, existing measures of acute brain dysfunction have been 
developed exclusively for the assessment of HE and have notable limitations. Limitations of 
the gold standard West Haven criteria include significant subjectivity and interrater 
variability (Bajaj et al. 2011). These limitations have been improved using the HE Scoring 
Algorithm, which incorporates neuropsychological assessments that are objective; however, 
this system requires significant time and expertise and is therefore not practical for routine 
HE assessment (Hassanein et al. 2009). HE assessment using other measures, such as the 
Clinical HE Staging Scale and the Modified-Orientation Log, are promising, but have not 
been widely validated (Ortiz et al. 2007; Salam et al. 2012). In contrast, CAM and CAM-
ICU have been validated across healthcare settings and are already used widely (Gusmao-
Flores et al. 2012; Wei et al. 2008). CAM-ICU can be administered in less than two minutes; 
it can be performed by various members of the healthcare team with minimal training; and it 
can be implemented in an ICU with high compliance and reliability (Ely et al. 2001; Pun et 
al. 2005; Soja et al. 2008). In comparison to general clinical judgement of HE severity, 
CAM-ICU is likely to be more reproducible and may offer more uniform recognition of 
delirium if used universally for screening. Indeed, the significant subjectivity and variability 
seen with the West Haven criteria is also likely to be seen in general clinical judgement. An 
additional strength of CAM-ICU is its accuracy in intubated patients and those receiving 
sedation (Ely et al. 2001). Indeed, in this study, sedated patients were the subject of most HE 
assessment interrater disagreements; in this group, RASS and CAM-ICU may provide a 
more uniform assessment of mental status.
Despite these strengths, CAM-ICU has several weaknesses that limit its impact. First, unlike 
the West Haven criteria and other measures, CAM-ICU is a purely binary diagnostic test and 
does not provide a quantification of delirium severity. Severity quantification is provided by 
other delirium measures, such as the Delirium Rating Scale, but these require significant 
expertise and are not practical for routine use (Trzepacz et al. 2001). A severity measure 
based on CAM has recently been developed and validated in an elderly population and may 
have value for patients with cirrhosis (Inouye et al. 2014). Another limitation of CAM-ICU 
is the potential for under-detection of delirium. Although CAM-ICU is highly sensitive for 
delirium in intubated patients, several studies have shown that its sensitivity may be 
diminished in healthier patients (McNicoll et al. 2005; Neufeld et al. 2011). Indeed, in this 
study, we also found a high sensitivity of CAM-ICU for HE in intubated patients and a high 
specificity in those who were not intubated.
A thorough discussion of the impact of delirium in cirrhosis is challenging because of the 
semantics inherent in describing delirium and encephalopathy. Delirium is a disturbance in 
attention, awareness, and cognition developing over a short period of time and fluctuating in 
severity (Diagnostic and statistical manual of mental disorders 2013). Delirium and 
encephalopathy are synonymous, but terminology for this condition varies widely, and other 
terms such as acute mental status change, confusion, and acute brain dysfunction are also 
used to describe this phenomenon (Morandi et al. 2008). Several authors have called for 
delirium terminology to be standardized to maintain clarity and have encouraged the use of 
“delirium” instead of other terms (Morandi et al. 2008). Whereas general delirium and 
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encephalopathy refer to the same phenomenon, HE is a wide-ranging spectrum of 
neurocognitive impairment occurring in the setting of liver disease specifically (Bajaj et al. 
2011). Overt HE refers to a clinically apparent change in mental status, and is, by definition, 
a subtype of delirium (Diagnostic and statistical manual of mental disorders 2013; Ferenci et 
al. 2002). Like general delirium, overt HE is often precipitated by infections, electrolyte 
disturbances, and volume imbalances. These similarities can make it difficult to discern 
whether HE is causing a specific episode of delirium; thus, patients with cirrhosis and 
delirium are often treated empirically for overt HE. Despite overt HE's definition as a 
subtype of delirium, this is the first study to our knowledge to assess HE using a delirium-
specific instrument.
The association between delirium and coma with poor clinical outcomes is not surprising, 
given similar findings in other populations (Ely et al. 2004; Klein Klouwenberg et al. 2014; 
McAvay et al. 2006; Milbrandt et al. 2004). In addition, the association between HE and 
increased mortality is well-established (Infante-Rivard et al. 1987; Jepsen et al. 2010). 
However, outcomes have not been previously described in critically ill patients with 
cirrhosis and delirium. Mortality in patients with cirrhosis in the ICU has been examined in 
several recently published studies. Increased mortality has been associated with several 
factors including liver-specific measures such as MELD (and its components) and Child-
Pugh, and general ICU measures such as Sequential Organ Failure Assessment, APACHE 
II, and the need for mechanical ventilation (Bahirwani et al. 2013; Cavallazzi et al. 2012; 
Cholongitas et al. 2012; Filloux et al. 2010; Levesque et al. 2012; Tu et al. 2011). In 
addition to these liver-specific and general ICU measures of disease severity, this study 
demonstrates that formal delirium assessment may have additional prognostic value. 
Although 15 of the patients in this study participated in the randomized trial of delirium 
management, only those with delirium were eligible for the trial; thus any effect of the trial 
intervention would bias the results toward the null. Our findings are also consistent with 
other papers showing relatively low mortality for patients with gastrointestinal bleeding 
(Shawcross et al. 2012) and a close relationship between delirium and infections (Shawcross 
et al. 2011).
Despite the novelty of these findings, this study has several limitations. First, although the 
size of the overall screened cohort was substantial, there were relatively few patients with 
cirrhosis (<3%). This low prevalence is likely due in part to the fact that WMH is not a 
transplant center. The only liver transplant center in the state is Indiana University Hospital, 
and that hospital provides much of the care for patients in the catchment area with end stage 
liver disease. Such referral patterns likely result in a selection bias where Indiana University 
Hospital provides care for more of the sicker patients, leaving a comparatively “healthy” 
population of individuals with cirrhosis at WMH. Indeed, MELD and mortality in this study 
were substantially less than in other similar cohorts (Bahirwani et al. 2013). Therefore, this 
study's findings need to be generalized to sicker populations in future studies. The low 
prevalence of cirrhosis at WMH also led to a relatively small sample size, which resulted in 
many statistically non-significant results and which limited our ability to perform 
multivariate analyses. We therefore used only one or two covariates in the regression 
models. However, the models' large effect estimates and consistent direction support a 
harmful impact of delirium on clinical outcomes. In addition, MELD and Child-Pugh have 
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excellent prognostic validity in cirrhosis, so the models controlling for these variables 
strongly support the relationships between delirium and outcomes. Furthermore, these 
findings are also consistent with prior work demonstrating poor outcomes with delirium in 
non-cirrhotic populations (Ely et al. 2004; McAvay et al. 2006). Another limitation of this 
study is the retrospective assessment of HE based on chart review. This design probably 
explains the HE assessment reviewer disagreement and also some of the CAM-ICU and HE 
disagreement. Since delirium is characterized by acute fluctuations, such disagreements 
would be expected when CAM-ICU and the clinical HE assessments are performed at 
different times during the day. Notably, reviewer disagreement was greatest in those who 
were intubated and sedated, the group in whom CAM-ICU is most reliable. Although we 
report the test characteristics of CAM-ICU and RASS in relation to HE, these analyses 
should be interpreted with extreme caution, as this study is lacking a true HE gold standard. 
In addition, it should be noted that disagreements between RASS/CAM-ICU and the HE 
assessment do not invalidate the pre-defined relationship between the underlying concepts 
(overt HE as a subtype of delirium); rather, the disagreements reflect differences between 
the specific instruments. Prospective real-time evaluations of HE should be included for 
comparison in future studies of CAM-ICU.
In conclusion, we found that delirium and coma as assessed using CAM-ICU and RASS is 
common in critically ill patients with cirrhosis and is associated with increased mortality and 
longer hospital stays. CAM-ICU is already recommended in clinical practice guidelines for 
the ICU and has been widely implemented in multiple clinical and research settings, and 
therefore may be a valuable tool for the care of hospitalized patients with cirrhosis. Further 
work is needed to better clarify the relationship between delirium and HE assessments and 
to investigate how standard delirium management may impact outcomes in patients with 
cirrhosis.
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Figure 1. 
Flowsheet of patients screened for delirium/coma who had cirrhosis.
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Table 1
Characteristics of patients with and without delirium/coma.
Delirium/coma − (N=65) Delirium/coma + (N=26) p-value
Age* 54.8 (8.6) 58.4 (9.2) 0.18
Sex, % male 67.7 53.9 0.24
Race/ethnicity, % 0.92
 Non-Hispanic white 61.5 57.7
 Non-Hispanic black 35.4 38.5
 Hispanic 3.1 3.8
Cirrhosis etiology, % 0.004
 Viral hepatitis 21.5 30.8
 Alcohol 24.6 38.5
 Viral + alcohol 44.6 11.5
 NASH 7.7 3.8
 Other 1.5 15.4
Principal discharge diagnosis, % 0.04
 Altered mental status 10.8 30.8
 GI bleeding 23.1 15.4
 Infection 12.3 23.1
 Other 53.9 30.8
Ascites, % 66.2 57.7 0.48
Hepatic encephalopathy, % 13.8 50.0 <0.001
Hepatocellular carcinoma, % 7.7 0.0 0.32
Acute physiology score* 6.5 (4.4) 10.4 (6.0) 0.003
Leukocyte count (109/L)* 7.9 (4.2) 8.1 (5.0) >0.99
Platelets (109/L)* 97 (54–132) 95 (73–126) 0.77
Sodium (mmol/L)* 135 (5.8) 135 (5.6) 0.76
Creatinine (mg/dL)* 0.9 (0.7–1.8) 1.1 (0.7–1.5) 0.38
Albumin (g/dL)* 2.9 (0.7) 2.9 (0.7) 0.72
Bilirubin (mg/dL)* 1.8 (0.9–3.8) 1.3 (1.0–2.9) 0.75
INR* 1.5 (0.4) 1.4 (0.3) 0.12
Ammonia (μmol/L)*† 48 (35–68) 44 (37–88) 0.90
Child-Pugh* 8.8 (2.4) 8.8 (2.2) 0.86
Child-Pugh, % A/B/C 25.0/35.9/39.1 19.2/34.6/46.2 0.84
MELD* 14.3 (8.3) 13.4 (6.5) 0.96
*Continuous variables presented as mean (SD) or median (IQR).
†Ammonia only available in 39/65 subjects without delirium/coma, compared to 23/26 with delirium/coma.
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Table 2
Mortality according to patient characteristics.
Inpatient mortality, % p-value 90-day mortality, % p-value
Delirium/coma 0.07 0.26
 Yes 23.1 30.8
 No 7.7 18.5
Age, mean (alive/dead) 55.9/55.8 0.96 55.7/56.4 0.79
Sex 0.52 0.43
 Male 10.3 19.0
 Female 15.2 27.3
Race/ethnicity 0.38 0.91
 Non-Hispanic white 16.4 21.8
 Non-Hispanic black 6.1 24.3
 Hispanic 0.0 0.0
Cirrhosis etiology 0.92 0.86
 Viral hepatitis 13.6 22.7
 Alcohol 11.5 23.1
 Viral + alcohol 12.5 25.0
 NASH 0.0 0.0
 Other 20.0 20.0
Principal discharge diagnosis 0.28 0.26
 Altered mental status 6.7 20.0
 GI bleeding 10.5 15.8
 Infection 28.6 42.9
 Other 9.3 18.6
Hepatic encephalopathy 0.13 0.02
 Yes 22.7 40.9
 No 8.7 15.9
Hepatocellular carcinoma 0.48 0.008
 Yes 20.0 80.0
 No 11.6 18.6
Acute physiology score, mean (alive/dead) 7.1/11.7 0.02 6.9/10.0 0.053
Child-Pugh 0.04 <0.001
 A 0.0 0.0
 B 9.4 12.5
 C 21.6 43.2
MELD, mean (alive/dead) 13.2/20.4 0.01 12.6/19.1 0.001
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Table 3
Association between delirium/coma and outcomes.
Model covariates Inpatient mortality OR 95% CI 90-day mortality OR 95% CI Length of stay IRR 95% CI
Unadjusted 3.6 (0.99–13.1) 2.0 (0.69–5.6) 2.5 (1.9–3.4)
Age and sex 3.7 (0.96–13.9) 1.8 (0.63–5.4) 2.7 (2.0–3.6)
MELD 5.4 (1.3–23.8) 2.4 (0.79–7.5) 2.5 (1.9–3.4)
Child-Pugh 4.2 (1.1–16.9) 2.4 (0.73–8.5) 2.5 (1.9–3.4)
Acute physiology score 2.2 (0.53–8.9) 1.3 (0.43–4.2) 2.2 (1.7–2.8)
Hepatic encephalopathy 2.8 (0.68–11.2) 1.2 (0.39–4.0) 2.7 (2.0–3.7)
HE and MELD 4.8 (1.01–23.1) 1.7 (0.48–5.8) 2.7 (2.0–3.7)
HE and APS 1.6 (0.36–7.1) 0.8 (0.24–2.9) 2.3 (1.8–3.0)
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